Limitations and use of PSA velocity in the diagnosis and characterization of prostate cancer.
Smith
Andrew D
AD
Beth Israel Medical Center in New York, NY 10003, USA.
Phillips
John L
JL
D018450:Disease Progression; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D017211:Treatment Failure
D017430:Prostate-Specific Antigen